Navitus Health Solutions

Recent Posts

Navitus to Remove Humira from Formularies June 1

Navitus to Remove Humira® from Formularies Effective June 1

More than ten biosimilars to Humira® were launched in 2023, introducing price competitiveness for one of the most utilized drugs on the market....

Read More
Industry News, Specialty
Q&A with David Simmons, Vice President, People and Culture

Executive Spotlight: David Simmons, Vice President, People and Culture

As Navitus Health Solutions celebrates its twenty-year legacy and looks ahead to the future, an area of focus is workplace culture. Our people are...

Read More
Employee Spotlight
Q&A with David Fields, President and Chief Executive Officer

Executive Spotlight: David Fields, President & CEO

This summer, Navitus celebrated its 20th anniversary as an organization. In honor of that, we sat down with David Fields to reflect on the company's...

Read More
Employee Spotlight

Celebrating 10 Years of Residency Program Excellence

2023 is a year of celebration at Navitus. Not only is it the 20th anniversary of our founding, but 2023 also marks 10 years of Navitus' residency...

Read More
Employee Spotlight

Humira Biosimilars – Update for October Formularies

Our recent August Pharmacy and Therapeutics (P&T) Committee meeting reviewed the release of various Humira® biosimilars. Staying true to our...

Read More
Industry News, Specialty

Legal Ease: A Navitus Government Affairs Update

In an ever-changing legislative landscape, we want to help our clients and partners stay informed of the latest happenings and how proposed policies...

Read More
Industry News

Humira Biosimilars – Summer of Blockbuster Releases for Navitus to Review

This summer has seen a continuation of the long-awaited market entry of Humira® (adalimumab) biosimilars. As of July 1, nine additional biosimilars...

Read More
Industry News, Specialty

Transforming Access to Pharmacy Benefits: 2022 Drug Trend Report

We are pleased to share our 2022 Drug Trend Report with you. This year's report highlights our success in managing pharmacy benefit costs for our...

Read More
Industry News
Q&A with George Hepburn, Chief Financial Officer

Employee Spotlight: George Hepburn

We had the pleasure of connecting with our new Chief Financial Officer, George Hepburn, to discuss what excites him about his new role, what inspires...

Read More
Employee Spotlight
Q&A with Ken Goodnight, Chief Transformation and Digital Officer

Employee Spotlight: Ken Goodnight

We recently sat down with Ken Goodnight to discuss his key priorities as Chief Transformation & Digital Officer and to learn about his professional...

Read More
Employee Spotlight

Humira Biosimilars Enter the Marketplace – Update on Navitus’ Review

The market entry of biosimilars to Humira® (adalimumab) is long-awaited. These products have the potential to improve affordability in the near- and...

Read More
Industry News, Specialty

Five Forecasts and Takeaways for Plan Sponsors in 2023

As we enter 2023, David Fields is sharing his top forecasts and takeaways for plan sponsors and the PBM industry.

Read More
Industry News, Specialty

Recent Posts